All companies
Visit website
META-BRAIN LABS
OperatingGenoEmote LLC, DBA Meta-Brain Labs
Technology · B2B · Founded 2021
Neurotech-enabled hyper-learning builds mental fitness, improving performance
Valuation cap ⓘ
$9.0M
As of Jan 2024 · from META-BRAIN LABS Future Equity SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$281,135
Across 1 round since 2023
Latest share price
$1.00
META-BRAIN LABS Future Equity SAFE 1 offering price
Financials
FY2020–FY2024 · from SEC filings · hover any figure for its source$0
2020
$0
−$6K
2021
$5K
$497
2023
$2K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2023
FY2024
Income statement
Revenue
$0
$0
$5,226
$2,000
Cost of goods sold
$0
$0
$4,729
$2,000
Gross margin
—
—
10%
0%
Net income
$0
-$6,247
$497
$0
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$9,781
$120,974
$32,285
Accounts receivable
$0
$0
$0
$0
Total assets
$0
$9,781
$120,974
$32,285
Short-term debt
$0
$16,028
$71,500
$71,500
Long-term debt
$0
$0
$0
$50,000
Total liabilities
$0
$16,028
$71,500
$121,500
Other
Headcount
—
6
—
6
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$9.0M
Valuation cap
META-BRAIN LABS Future Equity SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $281.1K / $1.2MInvestors 27Valuation cap $9M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 4 annual reports (FY2022–FY2025)
27 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001965811Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.